Cronos Group Inc. (NASDAQ:CRON) was the recipient of a significant increase in short interest in February. As of February 28th, there was short interest totalling 1,571,087 shares, an increase of Infinity from the February 15th total of 0 shares. Based on an average daily volume of 2,176,366 shares, the short-interest ratio is presently 0.7 days.
Separately, GMP Securities upgraded shares of Cronos Group from a “hold” rating to a “buy” rating in a research note on Friday.
NASDAQ CRON opened at $5.63 on Friday. Cronos Group has a 52-week low of $1.00 and a 52-week high of $11.90. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.54 and a current ratio of 4.92.
COPYRIGHT VIOLATION WARNING: “Cronos Group Inc. (CRON) Short Interest Up Infinity in February” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/short-interest-in-cronos-group-inc-cron-increases-by-infinity.html.
Cronos Group Company Profile
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada.
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.